University of Sydney · S1 2026 · FACULTY OF PHARMACY

PHAR2911 Pharmaceutics and Professional Practice

- one subject, every graph, every model, every mark
8 Chapters84-page Bible
Our own words - no uploaded lecturer files
Built to mirror S1 2026 · updated this semester
The Complete Exam Bible · S1 2026

PHAR2911 Overview

Pharmaceutics and Professional Practice
— one subject, every dosage form, every calculation, every mark
  • University of Sydney
  • S1 2026
  • 8 chapters
  • Pharmacy

Pharmaceutics and Professional Practice is the science of turning a drug into a medicine a patient can safely take — dosage-form design (tablets, capsules, liquids, semisolids), the physicochemistry of solubility and stability, micromeritics, extemporaneous compounding and dispensing, and the professional practice of counselling, medication safety and scheduling law.

  • Assessed by Final written exam see unit outline · Oral Communication & Clinical Decision-Making see unit outline + 3 more — Oral Communication & Clinical Decision-Making, Dispensing lab participation & professionalism are a hurdle
  • Key terms Dosage form, Dissolution, Micromeritics, BCS (Biopharmaceutics Classification System)
  • How to prepare Split your preparation in two.
Why read this guide

What you get in the full PHAR2911 Exam Bible

  1. 8 chapters, 84 pages — every examinable topic, week by week
  2. 7 original practice questions in the Final written exam format
  3. 8 worked examples, solved the way PHAR2911 marks
  4. 19 computed figures, redrawn from the course’s own numbers
  5. Exam-morning plan for the Final written exam — what to revise last, where marks are lost

Free on this page: assessment table, chapter map, one worked example, key terms, FAQ. The rest is in the full exam bible.

PHAR2911 · University of Sydney
An independent, AskSia-authored study guide. AskSia is not affiliated with, endorsed by, or sponsored by University of Sydney; the course code and name are used for identification only.
Assessment

How PHAR2911 is assessed

ComponentWeightFormat
Final written examsee unit outlineEnd-of-semester written exam covering the lecture course
Oral Communication & Clinical Decision-Making · hurdlesee unit outlineIn-person oral assessment (Week 9) · hurdle
Dispensing lab participation & professionalism · hurdlesatisfactory / unsatisfactoryContinuous across the dispensing labs · hurdle (accuracy of unit, label and calculation)
Pharmaceutics lab report + reflectionsee unit outlineGroup lab report (e.g. tablet analysis) + individual reflection
Mystery-shopping (MYSSA) activitysee unit outlineWork-integrated minor-ailment patient-care task (two visits + reflection)
Other students are asking · PHAR2911

What other students are asking about PHAR2911

Where can I find lecture notes or study guides for PHAR2911 at USyd?
The PHAR2911 study guide in AskSia Library covers Pharmaceutics and Professional Practice in 8 chapters, with the assessment table, a chapter-by-chapter topic map, key terms and a worked example, free to read on this page.
Is there a final exam in PHAR2911, and how much is it worth?
Yes. In the offering this AskSia Library guide is built from, Final written exam carries see unit outline of the PHAR2911 mark; the full split is Final written exam see unit outline, Oral Communication & Clinical Decision-Making see unit outline, Dispensing lab participation & professionalism satisfactory / unsatisfactory, Pharmaceutics lab report + reflection see.
What does PHAR2911 cover on solid dosage forms: tablets & quality control?
In AskSia Library's PHAR2911 guide, the Solid Dosage Forms: Tablets & Quality Control chapter explains compression · excipients · hardness/friability/disintegration/dissolution.
What does PHAR2911 cover on capsules: hard & soft?
In AskSia Library's PHAR2911 guide, the Capsules: Hard & Soft chapter explains hard-shell vs soft-gel · fill · capsule sizes.
What does PHAR2911 cover on micromeritics & particle characterisation?
In AskSia Library's PHAR2911 guide, the Micromeritics & Particle Characterisation chapter explains particle size & distribution · flow · effect on dissolution.
Weights, dates and every chapter are set out with their sources further down this page.
Contents · every chapter, one map

What PHAR2911 covers

From the molecule to the medicine the patient takes → one exam-ready map. Each topic links to its free chapter guide.

01

Dosage Forms & Routes of Administration

Solid · liquid · semisolid · the route–form map

This chapter is PHAR2911's foundational molecule-to-medicine map: how a bare drug substance is turned into a usable product by a formulation, and how the four physical states (solid, liquid, semisolid, aerosol) are matched to a route of administration.

  • Molecule to medicine: why we never give the bare drug
  • Formulation two meanings: the form (noun) vs the process (verb) + excipient roles
  • Route families: GI/enteral, parenteral, respiratory, skin, other
  • Local vs systemic intent drives the whole design
  • Four physical states mapped to routes: solid / liquid / semisolid / aerosol
  • Semisolid definitions: cream (o/w), lotion, ointment, gel, paste
02

Solid Dosage Forms: Tablets & Quality Control

Compression · excipients · hardness/friability/disintegration/dissolution

This chapter covers the compressed tablet as a dosage form: what it is made of (a small percentage of active drug surrounded by excipients), how powder becomes a hard compact by compression, and the pharmacopoeial (BP/Ph.Eur.) quality-control battery that releases a batch.

  • The five excipient jobs: diluent/filler, binder, disintegrant, lubricant, glidant
  • Compression in a die: direct compression vs wet granulation
  • Uniformity of mass: 20 tablets, 10/7.5/5% deviation bands by size
  • Uniformity of content: 10 tablets, 85-115% inner / 75-125% outer
  • Disintegration: 6 tablets, 37 C, the break-up step
  • Dissolution: >=75% in 45 min, the four BP apparatus
03

Capsules: Hard & Soft

Hard-shell vs soft-gel · fill · capsule sizes

This chapter covers the capsule as a solid oral dosage form: the hard capsule (a two-piece cap-and-body shell filled with powder or pellets) versus the soft capsule / softgel (a one-piece sealed shell holding a liquid or semisolid), plus shell chemistry, fill design and the capsule size ladder.

  • Hard (2-piece) vs soft (1-piece) capsule architecture
  • Gelatin shell: collagen origin, 13-16% moisture as plasticiser
  • Low-RH brittleness vs high-RH distortion (storage rule)
  • HPMC and other shell alternatives (DPI / vegetarian)
  • Capsule sizes: smaller number = larger capsule (000 to 5)
  • Powder fill excipients and how the dose is released
04

Micromeritics & Particle Characterisation

Particle size & distribution · flow · effect on dissolution

Micromeritics is the science of small particles — their size, shape, surface area and flow — and it is the quantitative core of PHAR2911 pharmaceutics.

  • Particle size as a distribution: mean vs mode vs median (d50)
  • Six equivalent-diameter definitions (Martin's, Feret's, projected-area, equivalent-volume, Stokes', aerodynamic)
  • Particle shape & specific surface area
  • Stokes' law & sedimentation (Andreasen) sizing
  • Choosing a sizing method by size range
  • Log-normal statistics: GSD = d84/d50 = d50/d16
05

Physicochemical Methods, Solubility & Stability

Solubility · pH-partition · BCS · stability & degradation

This chapter covers the physicochemical properties that decide whether an oral drug ever reaches the bloodstream — solubility versus dissolution, the pH-partition rule (Henderson–Hasselbalch + log P) for ionisable drugs, the BCS 2×2 of solubility × permeability, and the degradation pathways that fix a product's shelf life.

  • Solubility (equilibrium ceiling) vs dissolution (kinetic rate)
  • Noyes–Whitney: surface area, particle size & the ≥75%/45 min spec
  • pH-partition hypothesis & the unionised form
  • Henderson–Hasselbalch for weak acids and weak bases
  • log P and lipophilic membrane partitioning
  • BCS classes I–IV (solubility × permeability) & the rate-limiting step
06

Extemporaneous Compounding & Dispensing

Compounding · dispensing calculations · alligation

Extemporaneous compounding is preparing a medicine for an individual patient at the time of dispensing from raw ingredients, when no suitable licensed product exists.

  • When to compound: no product / dose / form / allergy
  • The dispensing record & QA declaration
  • Excess rules: capsules +2, beaker +10 g, suppositories +3
  • Method of doubling (geometric dilution)
  • Percentage strengths: % w/w vs % w/v vs % v/v
  • Parts and dilution (C₁V₁ = C₂V₂)
07

Professional Communication & Medication Safety

Patient counselling · harm minimisation · error prevention

This chapter is the practice half of PHAR2911: patient counselling, adherence, medication safety and risk communication — the canon that powers the Week-9 Oral Communication & Clinical Decision-Making Assessment and the practice-component written exam.

  • Communication as a two-way process: empathy, active listening, open vs closed questions
  • ISBAR handover structure and the patient-centred / biopsychosocial lens
  • The counselling checklist + teach-back to confirm understanding
  • Adherence vs compliance vs concordance; written medicines information (CMI)
  • Medication safety: blame culture vs system theory vs just culture
  • The Swiss-cheese model of layered dispensing defences
08

Risk Communication, Scheduling Law & Ethics

The Poisons Standard schedules · risk communication · ethics

This chapter is where pharmaceutics meets the law and the ethics of practice: it covers how the Poisons Standard (SUSMP) sorts medicines into schedules (S2/S3/S4/S8) that set who may supply what and how, how to communicate risk so patients actually act (the EPPM threat-vs-efficacy model), and the professional ethics, governance and medication-safety system that licences and constrains you.

  • The Poisons Standard / SUSMP schedules: S2, S3, S4, S8 and unscheduled
  • S3 (Pharmacist Only) supply duties + Appendix H advertising rule
  • Same drug, different schedule — the indication decides
  • Risk communication with the EPPM 2×2 (threat × efficacy)
  • Danger control vs fear control — why fear alone backfires
  • The PSA governance pyramid + AHPRA Code of Conduct

It is examined through an oral clinical-decision assessment (a hurdle), a final written exam, and dispensing labs marked on a satisfactory/unsatisfactory basis — so this guide teaches both the formulation science and the dispensing accuracy the assessments reward. Confirm this year's exact weights in your unit outline (the published assessment list marked them subject to confirmation).

Worked example · free

A dispensing dilution by alligation — mark by mark

Q [4 marks]. You need 100 g of a 5% w/w cream. You have a 10% w/w cream and a 2% w/w cream (the base). How much of each do you mix?
  • +2Set up alligation: target 5 in the middle; subtract diagonally. Parts of 10% = 5 − 2 = 3 parts; parts of 2% = 10 − 5 = 5 parts.
  • +1Total parts = 3 + 5 = 8, for 100 g total.
  • +1Mass of 10% cream = (3/8) × 100 = 37.5 g; mass of 2% cream = (5/8) × 100 = 62.5 g.
Mix 37.5 g of the 10% cream with 62.5 g of the 2% cream to make 100 g of 5% w/w.
Sia tip — Always check by mass balance: 37.5×0.10 + 62.5×0.02 = 3.75 + 1.25 = 5.0 g of drug in 100 g = 5% w/w. In dispensing, a wrong unit or calculation is marked unsatisfactory — verify every number.
Glossary

Key terms

Dosage form
The physical form in which a drug is delivered — tablet, capsule, solution, suspension, emulsion, cream, ointment — designed to deliver the right dose to the right site at the right rate.
Dissolution
The process by which a solid drug dissolves into solution; for many oral drugs it is the rate-limiting step for absorption, so dissolution testing is a key tablet quality control.
Micromeritics
The study of small particles — particle size and distribution, shape and surface area — which control powder flow, mixing, compaction and dissolution rate.
BCS (Biopharmaceutics Classification System)
A scheme classifying drugs by aqueous solubility and intestinal permeability into four classes, used to predict absorption behaviour and guide formulation.
Alligation
A dispensing calculation method for mixing two strengths of a preparation to obtain a required intermediate strength, using a diagonal subtraction to find the proportions.
Extemporaneous compounding
Preparing a medicine from individual ingredients for a specific patient at the time of dispensing, when no suitable manufactured product is available.
FAQ

PHAR2911 FAQ

How is PHAR2911 assessed?

Through an oral Communication & Clinical Decision-Making assessment (a hurdle, around Week 9), a final written exam, dispensing-lab participation and professionalism (a hurdle marked satisfactory/unsatisfactory), a pharmaceutics lab report with reflection, and a work-integrated mystery-shopping activity.

The exact weights are set in your unit outline — this year's published list marked them subject to confirmation, so check it.

Is PHAR2911 hard?

It combines formulation science (which is calculation- and concept-based) with hands-on dispensing accuracy and professional communication. The pressure points are the dispensing labs and the oral assessment, where a wrong calculation, unit or label is marked unsatisfactory — precision and practised counselling matter as much as theory.

What is pharmaceutics?

Pharmaceutics is the science of formulating and manufacturing medicines — choosing and designing the dosage form, ensuring the drug dissolves and is stable, and preparing and dispensing it safely. It is distinct from pharmacology (what the drug does to the body).

What's on the PHAR2911 written exam?

The lecture course: dosage forms and routes, tablets and quality control, capsules, micromeritics, physicochemical methods and stability, compounding and dispensing, and the professional-practice material (communication, medication safety, scheduling and ethics).

Is using AskSia for PHAR2911 cheating?

No. AskSia is a study reference written in our own words — we host none of your lecturer's files, and Sia teaches you the method to earn the marks; it does not complete or sit your assessments.

Chapter questions

Questions students ask in each PHAR2911 chapter

What is the difference between a cream, a lotion and an ointment?
All are topical semisolids. A cream is an oil-in-water emulsion that rubs in and washes off; a lotion is a runnier o/w system with higher water content; an ointment is an oily, thick, occlusive semisolid that holds drug against the skin. A paste is a stiff semisolid carrying a high solids load (about 20 to 50%), which makes it protective. Chapter 01 · Dosage Forms & Routes of Administration
What is the difference between disintegration and dissolution testing?
Disintegration only proves the tablet breaks up into smaller pieces (6 tablets, raised and lowered in 37 C water until all fully break apart). Dissolution measures how fast and how much drug actually goes into solution over time, against a spec such as >=75% released in 45 min. Dissolution is the step that limits absorption for a poorly-soluble drug, so it is the test that correlates with how the medicine works in the body; disintegration is just a prerequisite to it. Chapter 02 · Solid Dosage Forms: Tablets & Quality Control
Is a smaller capsule number bigger or smaller?
Bigger. The size system runs backwards: the smaller the number, the larger the capsule. Size 000 is the largest in common use (about 1.36 mL) and size 5 is the smallest (about 0.13 mL). When formulating you pick the smallest size that comfortably holds the fill, because smaller capsules are easier to swallow. Chapter 03 · Capsules: Hard & Soft
Why does smaller particle size speed up dissolution?
For a fixed mass, finer particles expose more total surface area, and dissolution rate is proportional to surface area (Noyes-Whitney). So particle-size reduction (micronisation) is the classic fix for a poorly-soluble drug. The catch: smaller, more cohesive particles flow worse, hurting mixing and dose uniformity — you have to state that trade-off. Chapter 04 · Micromeritics & Particle Characterisation
What is the difference between solubility and dissolution?
Solubility is the equilibrium ceiling — how much drug can dissolve in a solvent at a given temperature. Dissolution is the rate at which the solid gets there. A drug can be quite soluble yet dissolve slowly, or poorly soluble yet dissolve what little it can quickly. For most oral immediate-release products dissolution is the rate-limiting step for absorption, which is why exams test the distinction directly. Chapter 05 · Physicochemical Methods, Solubility & Stability
When is a pharmacist allowed to compound rather than dispense a licensed product?
Only when a clinical need cannot be met commercially: no licensed product exists for the drug, the required strength or dose is unavailable (e.g. a paediatric fraction), a different dosage form is needed (a liquid for someone who cannot swallow), or there is an allergy/intolerance to an excipient. A licensed product is preferred every time because it is GMP-manufactured and quality-controlled; you never compound just to make something cheaper or more convenient. Chapter 06 · Extemporaneous Compounding & Dispensing
What is the difference between adherence, compliance and concordance?
Compliance means the patient does as told (a paternalistic term falling out of favour); adherence means the patient follows a plan that was AGREED with them (the preferred term); concordance describes the shared, NEGOTIATED agreement on the plan itself. Note that non-adherence is often intentional — driven by a belief the drug is unnecessary or harmful — so address the belief, not just forgetfulness. Chapter 07 · Professional Communication & Medication Safety
What is the difference between S2, S3 and S4 medicines in Australia?
S2 (Pharmacy Medicine) can be sold in a pharmacy without a pharmacist's involvement; S3 (Pharmacist Only) must be personally handed over by the pharmacist with a chance to ask questions and stored out of public reach; S4 (Prescription Only) needs a valid prescription from an authorised prescriber. S8 (Controlled) adds locked storage and a strict register. The schedule, not the drug name, sets the supply rule. Chapter 08 · Risk Communication, Scheduling Law & Ethics
Study strategy

How to study for the exam

Split your preparation in two. For the written exam, learn each dosage form as a structure–property–quality-control triple (what it is, why it's formulated that way, how it's tested) and practise the dispensing calculations (alligation, dilutions, % w/w) until they are automatic and self-checked.

For the oral assessment and dispensing labs, rehearse patient counselling and double-check every unit, label and calculation — they are marked on accuracy, and one error is unsatisfactory. Verify all weights and dates against your own unit outline.

A+Everything unlocked
Unlocks this Bible + all 202 of your subjects at University of Sydney, plus 1,000+ more Bibles across the AskSia library.
Sia - your PHAR2911 tutor, unlimited, worked the way the exam marks it
The full 84-page Bible + practice bank with worked solutions
Chrome extension - sync your LMS so Sia knows your deadlines
Bilingual EN / Chinese on every Bible and every Sia answer
$0.99 Trial
30-day money-back · cancel in one tap · how it works
PHAR2911 · Pharmaceutics and Professional Practice - independent study guide on the AskSia Library. More University of Sydney subjects · Microeconomics across all universities